Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1976 1
1978 2
1980 1
1984 2
1989 1
1992 1
1997 1
1999 1
2000 1
2001 2
2002 1
2004 1
2005 1
2007 1
2008 2
2009 4
2010 2
2011 2
2012 4
2013 2
2014 6
2015 6
2016 6
2017 8
2018 5
2019 6
2020 10
2021 16
2022 15
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.
Jhaveri CD, Glassman AR, Ferris FL 3rd, Liu D, Maguire MG, Allen JB, Baker CW, Browning D, Cunningham MA, Friedman SM, Jampol LM, Marcus DM, Martin DF, Preston CM, Stockdale CR, Sun JK; DRCR Retina Network. Jhaveri CD, et al. N Engl J Med. 2022 Aug 25;387(8):692-703. doi: 10.1056/NEJMoa2204225. Epub 2022 Jul 14. N Engl J Med. 2022. PMID: 35833805 Free PMC article. Clinical Trial.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Maturi RK, Glassman AR, Josic K, Baker CW, Gerstenblith AT, Jampol LM, Meleth A, Martin DF, Melia M, Punjabi OS, Rofagha S, Salehi-Had H, Stockdale CR, Sun JK; DRCR Retina Network. Maturi RK, et al. JAMA. 2023 Feb 7;329(5):376-385. doi: 10.1001/jama.2022.25029. JAMA. 2023. PMID: 36749332 Free PMC article.
Biodegradable Peptide-Silica Nanodonuts.
Maggini L, Travaglini L, Cabrera I, Castro-Hartmann P, De Cola L. Maggini L, et al. Among authors: cabrera i. Chemistry. 2016 Mar 7;22(11):3697-703. doi: 10.1002/chem.201504605. Epub 2016 Feb 16. Chemistry. 2016. PMID: 26880470
Microbiota as key factors in inflammatory bowel disease.
White Z, Cabrera I, Kapustka I, Sano T. White Z, et al. Among authors: cabrera i. Front Microbiol. 2023 Oct 13;14:1155388. doi: 10.3389/fmicb.2023.1155388. eCollection 2023. Front Microbiol. 2023. PMID: 37901813 Free PMC article. Review.
[Anxiety and ageing].
Cabrera I, Montorio I. Cabrera I, et al. Rev Esp Geriatr Gerontol. 2009 Mar-Apr;44(2):106-11. doi: 10.1016/j.regg.2009.01.001. Epub 2009 Mar 5. Rev Esp Geriatr Gerontol. 2009. PMID: 19268391 Review. Spanish. No abstract available.
The Dimerization of Precocene I.
Fraga BM, Cabrera I. Fraga BM, et al. Among authors: cabrera i. Nat Prod Commun. 2017 May;12(5):691-694. Nat Prod Commun. 2017. PMID: 30496677
104 results